Key facts
- This page summarizes Julia Aijun Wang's Form 4 filing for BeiGene, Ltd. (ONC).
- 1 reported transaction and 0 derivative rows are listed below.
- Accepted by SEC: 03 Jul 2024, 17:05.
Julia Aijun Wang - 01 Jul 2024 Form 4 Insider Report for BeiGene, Ltd. (ONC)
- Reporting relationship
- Chief Financial Officer
- Issuer ticker
- ONC
- Reported as of
- 01 Jul 2024
- Net transaction value
- -$67,919
- SEC form
- 4
- Accepted by SEC
- 03 Jul 2024, 17:05:32 UTC
- Prior SEC filing
- 26 Jun 2024
- Next SEC filing
- 03 Dec 2024
- Source filing
- View source filing
- Reporting owner signature
- /s/ Qing Nian, as Attorney-in-Fact
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Julia Aijun Wang filed Form 4 for BeiGene, Ltd. (ONC) on 03 Jul 2024.
Change
- Previous filing in this sequence was filed on 26 Jun 2024.
- Current net transaction value: -$67,919.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
BGNE
transaction
American Depositary Shares
Sale
- Transaction value
- $67,919
- Shares
- -472
- Change %
- -100%
- Price
- $143.90
- Shares after
- 0
- Date
- 01 Jul 2024
- Ownership
- Direct
- Footnotes
- F1, F2, F3
BGNE
holding
Ordinary Shares
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 426,595
- Date
- 01 Jul 2024
- Ownership
- Direct
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 3 footnotes
Footnote F1
Each American Depositary Share represents 13 Ordinary Shares.
Footnote F2
The sale was effected pursuant to a mandatory tax withholding provision in the Reporting Person's restricted share unit award agreement in connection with the vesting of a restricted share unit award previously granted to the Reporting Person. 1/4th of the securities will vest on each anniversary of June 30, 2020, subject to continued service. Unvested securities are subject to accelerated vesting upon certain termination events.
Footnote F3
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $143.8513 to $144.06, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price.